fura-2 has been researched along with Uterine Cervical Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, WT; Chou, CY; Shen, MR | 1 |
| Chou, CY; Ellory, JC; Furla, P; Shen, MR | 1 |
2 other study(ies) available for fura-2 and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Streptomycin and its analogues are potent inhibitors of the hypotonicity-induced Ca2+ entry and Cl- channel activity.
Topics: Animals; Calcium; Calcium Signaling; Cell Line, Tumor; Cell Size; Chloride Channels; Chlorides; Dose-Response Relationship, Drug; Electrophysiology; Female; Fura-2; Humans; Hypotonic Solutions; Kidney; Patch-Clamp Techniques; Streptomycin; Time Factors; Uterine Cervical Neoplasms | 2003 |
Myosin light chain kinase modulates hypotonicity-induced Ca2+ entry and Cl- channel activity in human cervical cancer cells.
Topics: Algorithms; Antibodies, Monoclonal; Calcium; Calcium Signaling; Chloride Channels; Electric Stimulation; Electrophysiology; Female; Fluorescent Dyes; Fura-2; Humans; Hypotonic Solutions; Myosin-Light-Chain Kinase; Osmotic Pressure; Patch-Clamp Techniques; Phosphorylation; Taurine; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2002 |